(Q34645550)

3 August 2017

title

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study (English)

1 reference

3 August 2017

0 references

1 reference

C P Kelly

1

1 reference

3 August 2017

P H R Green

2

1 reference

3 August 2017

J A Murray

3

1 reference

3 August 2017

A Dimarino

4

1 reference

3 August 2017

A Colatrella

5

1 reference

3 August 2017

D A Leffler

6

1 reference

3 August 2017

T Alexander

7

1 reference

3 August 2017

R Arsenescu

8

1 reference

3 August 2017

F Leon

9

1 reference

3 August 2017

J G Jiang

10

1 reference

3 August 2017

L A Arterburn

11

1 reference

3 August 2017

B M Paterson

12

1 reference

3 August 2017

R N Fedorak

13

1 reference

3 August 2017

Larazotide Acetate Celiac Disease Study Group

14

1 reference

3 August 2017

language of work or name

English

0 references

publication date

19 November 2012

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

published in

1 reference

3 August 2017

volume

37

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

252-262

1 reference

The many faces of celiac disease: clinical presentation of celiac disease in the adult population

3 August 2017

cites work

1 reference

Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001.

21 January 2018

1 reference

21 January 2018

1 reference

Risk of malignancy in patients with celiac disease.

21 January 2018

1 reference

Factors that influence adherence to a gluten-free diet in adults with celiac disease

21 January 2018

1 reference

Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage

21 January 2018

1 reference

Duodenal histology in patients with celiac disease after treatment with a gluten-free diet

21 January 2018

1 reference

Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet

21 January 2018

1 reference

National Institutes of Health Consensus Development Conference statement on Celiac Disease, June 28–30, 2004

21 January 2018

1 reference

Celiac disease: pathogenesis of a model immunogenetic disease

21 January 2018

1 reference

Alterations in intestinal permeability

21 January 2018

1 reference

Epithelial Tight Junction Structure in the Jejunum of Children with Acute and Treated Celiac Sprue

21 January 2018

1 reference

In vivo and in vitro permeability in coeliac disease

21 January 2018

1 reference

Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins.

21 January 2018

1 reference

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

21 January 2018

1 reference

Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application

21 January 2018

1 reference

Larazotide acetate regulates epithelial tight junctions in vitro and in vivo.

21 January 2018

1 reference

Larazotide acetate promotes tight junction assembly in epithelial cells

21 January 2018

1 reference

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

21 January 2018

1 reference

A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge

21 January 2018

1 reference

Characteristics of adult celiac disease in the USA: results of a national survey

21 January 2018

1 reference

Pilot study on the effect of linaclotide in patients with chronic constipation

21 January 2018

1 reference

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12147

1 reference

3 August 2017

1 reference